Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug

References

• Akhtar MJ, Ahamed M, Kumar S, Khan MMA, Ahmad J, Alrokayan SA. 2012. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine. 7:845–857.
   PubMed Web of Science ®Google Scholar
• Bender EA, Adorne MD, Colomé LM, Abdalla DSP, Guterres SS, Pohlmann AR. 2012. Hemocompatibility of poly(ϵ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm. 426:271–279.
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. 2008. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 7:771–782.
   PubMed Web of Science ®Google Scholar
• Deerinck TJ. 2008. The application of fluorescent quantum dots to confocal, multiphoton, and electron microscopic imaging. Toxicol Pathol. 36:112–116.
   PubMed Web of Science ®Google Scholar
• Degen A, Kosec M. 2000. Effect of pH and impurities on the surface charge of zinc oxide in aqueous Solution. J Eur Ceramic Soc. 20:667–673.
   Web of Science ®Google Scholar
• Elbialy NS, Fathy MM, Khalil WM. 2014. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers. Phys Med. 30:843–848.
   PubMed Web of Science ®Google Scholar
• Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. 2011. Silver nanoparticles as potential antiviral agents. Molecules. 16:8894–918.
   PubMed Web of Science ®Google Scholar
• Gilmore JL, Yi X, Quan L, Kabanov AV. 2008. Novel nanomaterials for clinical neuroscienceNovel Nanomaterials for Clinical Neuroscience. J Neuroimmune Pharmacol. 3:83–94.
   PubMed Web of Science ®Google Scholar
• Guo D, Wua C, Jiang H, Li Q, Wanga X, Chen B. 2008. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. J Photochem Photobiol B. 93:119–126.
   PubMed Web of Science ®Google Scholar
• Hanley C, Layne J, Punnoose A, Reddy KM, Coombs I, Coombs A, et al. 2008. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology. 19:295103.
   PubMed Web of Science ®Google Scholar
• He F, Zhao D. 2005. Preparation and characterization of a new class of starch-stabilized bimetallic nanoparticles for degradation of chlorinated hydrocarbons in water. Environ Sci Technol. 39:3314–3320.
   PubMed Web of Science ®Google Scholar
• Hong H, Shi J, Yang Y, Zhang Y, Engle JW, Nickles RJ, et al. 2011. Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Lett. 11:3744–3750.
   PubMed Web of Science ®Google Scholar
• Kievit FM, Wang FY, Fang C, Mok H, Wang K, Silber JR, et al. 2011. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release. 152:76–83.
   PubMed Web of Science ®Google Scholar
• Kim K, Lee M, Park H, Kim JH, Kim S, Chung H, et al. 2006. Cell- permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J Am Chem Soc. 128:3490–3491.
   PubMed Web of Science ®Google Scholar
• Kohler N, Sun C, Fichtenholtz A, Gunn J, Fang C, Zhang M. 2006. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small. 2:785–792.
   PubMed Web of Science ®Google Scholar
• Lai JR, Chang YW, Yen HC, Yuan NY, Liao MY, Hsu CY, et al. 2010. Multifunctional doxorubicin/superparamagnetic iron oxide- encapsulated Pluronic F127 micelles used for chemotherapy/magnetic resonance imaging. J Appl Phys. 107:09B318.
   Web of Science ®Google Scholar
• Lee JH, Kim YG, Cho MH, Lee J. 2014. ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production. Microbiol Res. 169:888–896.
   PubMed Web of Science ®Google Scholar
• Maeng JH, Lee DH, Jung KH, Bae YH, Park IS, Jeong S, et al. 2010. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials. 31:4995–5006.
   PubMed Web of Science ®Google Scholar
• Montet X, Weissleder R, Josephson L. 2006. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem. 17:905–911.
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, et al. 2005. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 11:3530–3534.
   PubMed Web of Science ®Google Scholar
• Nair S, Sasidharan A, Rani VVD, Menon D, Nair S, Manzoor K, Raina S. 2009. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci. 20:S235–S241
   Web of Science ®Google Scholar
• Nam J, La WG, Hwang S, Ha YS, Park N, Won N, et al. 2013. pH- responsive assembly of gold nanoparticles and “spatiotemporally concerted” drug release for synergistic cancer therapy. ACS Nano. 7:3388–3402.
   PubMed Web of Science ®Google Scholar
• Nasrolahi Shirazi A, Tiwari RK, Oh D, Sullivan B, McCaffrey K, Mandal D, Parang K. 2013. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters. Mol Pharm. 10:3137–3151.
   PubMedGoogle Scholar
• Nobili S, Landini I, Giglioni B, Mini E. 2006. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets. 7:861–879.
   PubMed Web of Science ®Google Scholar
• Palanikumar L, Ramasamy S, Hariharan G, Balachandran C. 2013. Influence of particle size of nano zinc oxide on the controlled delivery of Amoxicillin. Applied Nanoscience. 3:441–451.
   Web of Science ®Google Scholar
• Palanikumar L, Ramasamy SN, Balachandran C. 2014. Size-dependent antimicrobial response of zinc oxide nanoparticles. IET Nanobiotechnol. 8:111–117.
   PubMed Web of Science ®Google Scholar
• Panariti A, Miserocchi G, Rivolta I. 2012. The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl. 5:87–100.
   PubMedGoogle Scholar
• Ramanujan RV, Kayal S. 2010. Anti-cancer drug loaded iron–gold core–shell nanoparticles (Fe@Au) for magnetic drug targeting. J NanosCNanotechnol. 10:1–13.
   Web of Science ®Google Scholar
• Reddy LS, Nisha MM, Joice M, Shilpa PN. 2014. Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae. Pharm Biol. 52:1388–1397.
   PubMed Web of Science ®Google Scholar
• Seker S, Eser Elçin A, Yumak T, Sınağ A, Murat Elçin Y. 2014. In Vitro cytotoxicity of hydrothermally synthesized ZnO nanoparticles on human periodontal ligament fibroblast and mouse dermal fibroblast cells. Toxicol In Vitro. 28:1349–1358.
   PubMed Web of Science ®Google Scholar
• Son SJ, Bai X, Lee SB. 2007. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Dru.g/gene delivery applications. Drug Discov Today 12:650–656.
   Google Scholar
• Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, et al. 2008. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Nanomedicine. 3:495–505.
   PubMed Web of Science ®Google Scholar
• Sun TM, Wang YC, Wang F, Du JZ, Mao CQ, Sun CY, et al. 2014. Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds. Biomaterials. 35:836–845.
   PubMed Web of Science ®Google Scholar
• Taccola L, Raffa V, Riggio C, Vittorio O, Iorio MC, Vanacore R, et al. 2011. Zinc oxide nanoparticles as selective killers of proliferating cells. Int J Nanomedicine. 6:1129–1140.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Kievit FM, Fang C, Mu N, Jana S, Leung MC, et al. 2010. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials. 31:8032–8042.
   PubMed Web of Science ®Google Scholar
• Vimala K, Sundarraj S, Paulpandi M, Vengatesan S, Kannan S. 2014. Green synthesized doxorubicin loaded zinc oxide nanoparticlesregulates the Bax and Bcl-2 expression in breast and colon carcinoma. Process Biochem. 49 (1)::160–172.
   Web of Science ®Google Scholar
• Wang H, Wingett D, Engelhard MH, Feris K, Reddy KM, Turner P, et al. 2009. Fluorescent dye encapsulated ZnO particles with cell specific toxicity for potential use in biomedical applications. J Mater Sci Mater Med. 20:11–22.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Hong H, Matson VZ, Javadi A, Xu W, Yang Y, et al. 2012. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics. 2:757–768.
   PubMed Web of Science ®Google Scholar
• Yadav A, Prasad V, Kathe AA, Raj S, Yadav D, Sundaramoorthy C, Vigneshwaran N. 2006. Functional finishing in cotton fabrics using zinc oxide nanoparticles. Bull Mater Sci. 29:641–645.
   Web of Science ®Google Scholar
• Zhang Y, Wei C, Wang S, Liu Y, Pope C. 2008. Phototoxicity of zinc oxide nanoparticle conjugatesin human ovarian cancer NIH: OVCAR-3 cells. J Biomed Nanotechnol. 4:432–438.
   Web of Science ®Google Scholar